About Renovis Pharma
Renovis Pharma is a Healthcare company based in United States founded in 2020. It serves as a CDMO specializing in drug development services. It operates on a B2B model. Its Indian entity Ils Labs India Private Limited reported revenue of ₹9 Lakh. Its focus areas include Pharmaceuticals, Drug Development and Contract Manufacturing. Similar companies include Nephron Pharmaceuticals, AmbioPharm and Aiolos Bio; 3 of its 3 listed similar companies have raised funding.
Company details
Renovis Pharma, established in 2020, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and contract manufacturing. Serves as a CDMO specializing in drug development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters United States
- Employees 1
- SectorsHealthcare
- Website renovis-labs.com
- Legal Name Ils Labs India Private Limited
- Date of Incorporation 01 Dec, 2021
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹9 Lakh
FY 2025 · -28% YoY
- Indian entity net loss-₹1.06 Cr
FY 2025 · -1187% margin
- Indian entity EBITDA-₹1.05 Cr
FY 2025 · -1169% margin
- Employee Count1
Associated legal entities of Renovis Pharma
Renovis Pharma operates through Ils Labs India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ils Labs India Private Limited CIN U24299TG2021PTC157525 | Active | 01 Dec 2021 | Hyderabad, Telangana | ₹0.1 Cr | 4 | View details |
Board of directors of Ils Labs India Private Limited (Renovis Pharma)
Ils Labs India Private Limited is the primary company behind Renovis Pharma. The board of Ils Labs India Private Limited currently have 4 directors; the longest-serving is Aman Iqbal, appointed in 2021. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aman Iqbal DIN 08174387 | Director | 01 Dec 2021 | 4 yrs 11 mo | Ils Labs India Private Limited |
| Javed Iqbal DIN 02646782 | Director | 28 Jan 2022 | 4 yrs 9 mo | Ils Labs India Private Limited |
| Shrihari Pulagam DIN 08549530 | Director | 10 May 2022 | 4 yrs 6 mo | Ils Labs India Private Limited |
| Suryanarayana Reddy Pulagam DIN 00768424 | Director | 19 Sep 2022 | 4 yrs 1 mo | Ils Labs India Private Limited |
Financials of Renovis Pharma
Figures of Ils Labs India Private Limited, the primary company behind Renovis Pharma, for FY 2025. Revenue was ₹9 Lakh (-28% year on year). Net loss was -₹1.06 Cr (-1187% margin). EBITDA was -₹1.05 Cr (-1169% margin).
- ₹9 LakhRevenue · FY 2025 · -28% YoY
- -₹1.06 CrNet loss · -1187% margin
- -₹1.05 CrEBITDA · -1169% margin
- ₹20,410Paid-up capital
Balance sheet, profit and loss, cash flow and ratios of Ils Labs India Private Limited are on its company page.
Detailed financial statements for Renovis Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Renovis Pharma
Renovis Pharma has 3 listed similar companies in our database, 3 of them funded. They include Nephron Pharmaceuticals, AmbioPharm and Aiolos Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nephronpharm.com | 1937 | Florida, Puerto Rico | $625M | 1,578 | Sterile pharmaceutical products are manufactured and contract services are provided. | |
| ambiopharm.com | 2006 | North Augusta, United States | $24M | 186 | CDMO and analytical services for peptide development are provided. | |
| aiolosbio.com | 2023 | Boston, United States | $245M | Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions |
Detailed similar companies of Renovis Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Renovis Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Renovis Pharma
Complete news archive for Renovis Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renovis Pharma
Renovis Pharma was founded in 2020.
Renovis Pharma is headquartered in United States.
Renovis Pharma has 1 employees.
The primary company behind Renovis Pharma, Ils Labs India Private Limited, reported revenue of ₹9 Lakh for FY 2025, down 28% year on year.
Renovis Pharma, established in 2020, excels in providing healthcare solutions, producing pharmaceutical products, drug development, and contract manufacturing. Serves as a CDMO specializing in drug development services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Renovis Pharma's top competitors include Nephron Pharmaceuticals, Aiolos Bio and AmbioPharm.
Renovis Pharma operates through Ils Labs India Private Limited.
The legal entities of Renovis Pharma currently have 4 directors, including Shrihari Pulagam, Suryanarayana Reddy Pulagam, Javed Iqbal and others.